In vivo extravasated human monocytes have an altered expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1
- PMID: 19751271
- DOI: 10.1111/j.1365-3083.2009.02306.x
In vivo extravasated human monocytes have an altered expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1
Abstract
The phenotypic alterations in monocytes induced by extravasation in vivo are still largely unknown. We addressed the question whether a general phenotype of extravasated monocytes exists and whether this phenotype differs between healthy individuals and statin treated patients with coronary artery disease (CAD). In vivo extravasated monocytes from CAD patients and healthy controls were collected by use of the skin blister method and compared with peripheral circulating monocytes by flow cytometry. The number of CD14(+)CD16(+) monocytes were significantly higher in the skin blister compared with peripheral circulation in both patients (P < 0.001) and controls (P = 0.005). In vivo extravasated monocytes had in comparison with peripheral monocytes a lower expression of CX(3)CR1, a higher expression of HLA-DR, CD86 and CD36 and a higher binding of acetylated low density lipoprotein (acLDL) (significant for all markers). Skin blister fluid from CAD patients, compared with healthy controls, induced a 20% increase in monocyte CD36 expression (P = 0.008) following 18 h of in vitro incubation. The results indicate that the integrated response to the in vivo extravasation process is similar in statin treated stable CAD patients and healthy controls, with respect to phenotypic alterations. Such differences in CAD patients may, however, occur as a response to the inflammatory milieu.
Similar articles
-
Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.Brain Behav Immun. 2009 Feb;23(2):232-9. doi: 10.1016/j.bbi.2008.09.013. Epub 2008 Oct 4. Brain Behav Immun. 2009. PMID: 18930806 Clinical Trial.
-
Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro.Coron Artery Dis. 2007 Nov;18(7):523-31. doi: 10.1097/MCA.0b013e3282eff1ad. Coron Artery Dis. 2007. PMID: 17925605
-
HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation.Transpl Immunol. 2008 May;19(2):152-7. doi: 10.1016/j.trim.2008.02.002. Epub 2008 Mar 31. Transpl Immunol. 2008. PMID: 18503891 Clinical Trial.
-
Monocyte gene expression and coronary artery disease.Curr Opin Clin Nutr Metab Care. 2013 Jul;16(4):411-7. doi: 10.1097/MCO.0b013e32836236f9. Curr Opin Clin Nutr Metab Care. 2013. PMID: 23739627 Review.
-
The CD14+ CD16+ blood monocytes: their role in infection and inflammation.J Leukoc Biol. 2007 Mar;81(3):584-92. doi: 10.1189/jlb.0806510. Epub 2006 Nov 29. J Leukoc Biol. 2007. PMID: 17135573 Review.
Cited by
-
Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease.Clin Exp Immunol. 2010 Aug;161(2):332-41. doi: 10.1111/j.1365-2249.2010.04177.x. Epub 2010 May 7. Clin Exp Immunol. 2010. PMID: 20456413 Free PMC article.
-
CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation.BMC Immunol. 2014 Feb 6;15:4. doi: 10.1186/1471-2172-15-4. BMC Immunol. 2014. PMID: 24499053 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous